The wait is over

The UK's National Health Service is notorious for its waiting time for surgery. The Scottish Government recently decided to tackle this issue and proposed a Patient Rights Bill which includes a legal right to surgery within twelve weeks .

The Scottish Government proposed a legal right to surgery within twelve weeks.
The Scottish Government proposed a legal right to surgery within twelve weeks.

The Patient Rights Bill could be a life line for some seriously ill people since it calls for a legal right to treatment within twelve weeks from the GP’s referral to surgery. Furthermore, the document suggests a “no fault” compensation scheme. At present only patients who suffered legally established negligence receive financial help.

Currently, there is a non-binding target of 18 weeks from referral by a GP to being seen by a consultant and a further 18 weeks until hospital treatment.

The NHS is working towards a maximum 18 week wait by 2011.

The 12 weeks proposed in the draft Patient Rights Bill would be within the 18 weeks and would apply “once in-patient or day case treatment has been agreed as the most appropriate way forward”.

The proposal also calls for independent patient rights officers for every health board area, and clearly defined systems of feedback and redress.

 

07.10.2008

Related articles

Photo

News • "Gene scissors" vs. sickle cell disease

FDA approves first CRISPR/Cas therapy

It's an important milestone for gene editing technology: a novel treatment for sickle cell disease utilizing CRISPR-Cas9, has now received FDA approval – a first for this type of therapy.

Photo

News • National policies benchmark

Dementia care and treatment: Continuing inequalities across Europe

According to the European Dementia Monitor, there is still a clear East/West divide, with significant differences between countries in terms of availability, affordability, legal and human rights.

Photo

News • Potential and pitfalls of CRISPR

Gene therapies raise difficult legal and ethical questions

New advanced therapies can alleviate or cure chronic diseases. But medical progress, such as the gene editing tool CRISPR, raises the question of how rights should be protected and balanced.

Subscribe to Newsletter